Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial

Table 2

The baseline characteristics of subjects among the three groups.

Group	1	2	3	value
Gender (M/F)	5/5	14/12	26/9	0.16
Age (year)				0.06
Duration (month)				0.89
Numbers of OADs ()				0.06
1	1	8	2
2	8	12	24
3	1	6	9
OADs
Met(-/+)	4/6	7/19	4/31	0.10
SU (-/+)	2/8	9/17	5/30	0.17
Weight (kg)				0.13
BMI (kg/m^2)				0.29
Waist (cm)				0.41
Hb (g)				0.48
Cr (mmol/L)				0.26
ALT (U/L)				0.34
AST (U/L)				0.91
TG (mmol/L)				0.94
TC (mmol/L)				0.59
HDL (mmol/L)				0.09
LDL (mmol/L)				0.98

BMI: body mass index; Hb: hemoglobin; Cr: creatinine; ALT: alanine aminotransferase; AST: aspartate aminotransferase; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol; TG: triglyceride; TC: total cholesterol; OADs: oral antidiabetic drugs; Met: metformin; SU: sulfonylurea.